Filter by:

Reset Filter
  • Life Sciences
Showing 37 - 48 of 67
Press Release

bodog online casino

Intellectual Asset Management (IAM) names Henry Grabowski of Duke University and Matthew Lynde of Cornerstone Research in its annual list of leading expert witnesses on patent issues in the United…

Case

In re Intuniv Antitrust Litigation

The judge denied class certification in this pharmaceutical pay-for-delay case brought by a class of indirect purchasers.

Case

Cigna’s Acquisition of Express Scripts

The parties completed a $67 billion merger after receiving clearance from the U.S. Department of Justice and state departments of insurance.

Case

Hsu et al. v. Puma Biotechnology Inc. et al.

Positive jury verdict in rare securities class action trial.

Event

Competition Law and Economics in Pharmaceutical Markets

Cornerstone Research hosted expert forums in London and Brussels to examine recent competition cases in Europe.

Case

Product Hopping

Pharmaceutical manufacturers have been accused of engaging in product hopping by bodog app download introducing modified versions of branded drugs nearing patent expiry while simultaneously withdrawing the older drugs to hinder generic substitution.

Case

Sampling in FCA Litigation

Clients draw on Cornerstone Research's statistical expertise to evaluate sampling analyses performed by opposing parties to prove liability and damages in False Claims Act litigation.

Case

Joint Development Marketing Dispute

Cornerstone Research worked with a life sciences competition expert in a dispute between two pharmaceutical companies that jointly developed a drug.

Case

Allergan Takeover Bid

Cornerstone Research worked with two experts who testified on Rule 14e-3 allegations that a hedge fund violated federal securities law on disclosures in cash tender offers.

Case

Alleged Theft of Trade Secrets for a Drug in Development

Professor Sean Nicholson and Cornerstone Research analyzed the loss in value of a drug in development due to the advantage that the manufacturer of a competing drug in development obtained…

Case

Breach of Contract for a Branded Drug

Cornerstone Research and an affiliated expert analyzed the impact on a branded drug's value when a pharmaceutical company interrupted the supply and promotion of the drug.

Case

Section 337 Unfair Import Investigation of Medical Devices

Cornerstone Research worked with a healthcare and competition expert in a patent infringement matter before the ITC.

How can we help you?

If you are looking for a publication not on our website, contact us.